ICD-10 Coding for Peritoneal Carcinomatosis(C16.9, C48.2, C48.2B)
Comprehensive guide to ICD-10 coding for peritoneal carcinomatosis, including primary and secondary codes, documentation requirements, and common pitfalls.
Complete code families applicable to Peritoneal Carcinomatosis
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C78.6 | Secondary malignant neoplasm of retroperitoneum and peritoneum | Use when peritoneal carcinomatosis is secondary to another primary cancer. |
|
| C48.2 | Malignant neoplasm of peritoneum, unspecified | Use when primary peritoneal cancer is diagnosed without a known primary elsewhere. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutPeritoneal Carcinomatosis
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Peritoneal Carcinomatosis.
Omitting primary cancer site in documentation
Impact
Clinical: Misguides treatment planning., Regulatory: Non-compliance with coding standards., Financial: Potential claim denials.
Mitigation
Cross-reference with oncology records., Ensure comprehensive history taking.
Coding secondary peritoneal cancer as primary
Impact
Reimbursement: Incorrect reimbursement due to misclassification., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate cancer registry data.
Mitigation
Verify and document the primary cancer site before coding.
Incorrect coding of primary vs. secondary neoplasms
Impact
Misclassification can lead to audit flags.
Mitigation
Thorough documentation and verification of primary cancer sites.